Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.

Heidenreich A, Pfister D.

Curr Opin Urol. 2020 Jan;30(1):90-97. doi: 10.1097/MOU.0000000000000691.

PMID:
31724996
2.

Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.

Heidenreich A, Fossati N, Pfister D, Suardi N, Montorsi F, Shariat S, Grubmüller B, Gandaglia G, Briganti A, Karnes RJ.

Eur Urol Oncol. 2018 May;1(1):46-53. doi: 10.1016/j.euo.2018.03.002. Epub 2018 May 15.

PMID:
31100228
3.

Role of surgery in oligometastatic prostate cancer.

Jenjitranant P, Touijer KA.

Prostate Int. 2019 Dec;7(4):125-130. doi: 10.1016/j.prnil.2019.10.001. Epub 2019 Dec 3. Review.

4.

Role of radical prostatectomy in metastatic prostate cancer: A review.

Metcalfe MJ, Smaldone MC, Lin DW, Aparicio AM, Chapin BF.

Urol Oncol. 2017 Apr;35(4):125-134. doi: 10.1016/j.urolonc.2017.01.001. Epub 2017 Feb 9. Review.

PMID:
28190749
5.

Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.

Heidenreich A, Pfister D, Porres D.

J Urol. 2015 Mar;193(3):832-8. doi: 10.1016/j.juro.2014.09.089. Epub 2014 Sep 22.

PMID:
25254935
6.

Cytoreductive radical prostatectomy in metastatic prostate cancer: Does it really make sense?

Mathieu R, Korn SM, Bensalah K, Kramer G, Shariat SF.

World J Urol. 2017 Apr;35(4):567-577. doi: 10.1007/s00345-016-1906-3. Epub 2016 Aug 8. Review.

PMID:
27502935
7.

[Radical cancer surgery of renal cell and prostate carcinoma with hematogenous metastasis: benefits].

Heidenreich A, Pfister D, Porres D.

Urologe A. 2014 Jun;53(6):823-31. doi: 10.1007/s00120-014-3519-z. Review. German.

PMID:
24824471
8.

Emerging role of cytoreductive prostatectomy in patients with metastatic disease.

Jaber Y, Reichard CA, Chapin BF.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S505-S513. doi: 10.21037/tau.2018.06.06. Review.

9.

[Cytoreductive radical prostatectomy for prostate cancer with minimal osseous metastases: results of a first feasibility and case control study].

Heidenreich A, Pfister D, Brehmer B, Porres D.

Urologe A. 2015 Jan;54(1):14-21. doi: 10.1007/s00120-014-3697-8. German.

PMID:
25519996
10.

Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study.

Steuber T, Berg KD, Røder MA, Brasso K, Iversen P, Huland H, Tiebel A, Schlomm T, Haese A, Salomon G, Budäus L, Tilki D, Heinzer H, Graefen M, Mandel P.

Eur Urol Focus. 2017 Dec;3(6):646-649. doi: 10.1016/j.euf.2017.06.016. Epub 2017 Jul 8.

PMID:
28753877
11.

[Surgical treatment of local disease in metastatic prostate cancer.]

Gaya JM, Huguet J, Breda A, Palou J.

Arch Esp Urol. 2018 Mar;71(3):288-297. Review. Spanish.

PMID:
29633950
12.

Cytoreductive prostatectomy in metastatic prostate cancer: current knowledge and future directions.

Polotti CF, Sterling JA, Kim IY.

Am J Clin Exp Urol. 2019 Apr 25;7(2):80-84. eCollection 2019. Review.

13.

A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?

Slaoui A, Albisinni S, Aoun F, Assenmacher G, Al Hajj Obeid W, Diamand R, Regragui S, Touzani A, Bakar A, Mesfioui A, Karmouni T, Ameur A, Elkhader K, Koutani A, Ibnattya A, Roumeguere T, Peltier A.

World J Urol. 2019 Nov;37(11):2343-2353. doi: 10.1007/s00345-019-02652-7. Epub 2019 Jan 31.

PMID:
30706122
14.

Radical prostatectomy in oligometastatic prostate cancer.

Mandel P, Steuber T, Graefen M.

Curr Opin Urol. 2017 Nov;27(6):572-579. doi: 10.1097/MOU.0000000000000445. Review.

PMID:
28825924
15.

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer.

Yuh BE, Kwon YS, Shinder BM, Singer EA, Jang TL, Kim S, Stein MN, Mayer T, Ferrari A, Lee N, Parikh RR, Ruel N, Kim WJ, Horie S, Byun SS, Ahlering TE, Kim IY.

Prostate Int. 2019 Sep;7(3):102-107. doi: 10.1016/j.prnil.2018.10.002. Epub 2018 Oct 25.

16.

Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up.

Gandaglia G, Fossati N, Stabile A, Bandini M, Rigatti P, Montorsi F, Briganti A.

Eur Urol. 2017 Aug;72(2):289-292. doi: 10.1016/j.eururo.2016.08.040. Epub 2016 Aug 27.

PMID:
27574820
17.

[Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].

Heidenreich A, Ohlmann C, Ozgür E, Engelmann U.

Urologe A. 2006 Apr;45(4):474-81. German.

PMID:
16465521
18.

Current concepts in oligometastatic prostate cancer: Is there a role for radical prostatectomy?

Marenco J, Sooriakumaran P.

Arch Esp Urol. 2019 Mar;72(2):174-181. Review.

PMID:
30855019
19.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
20.

Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2010;10(27):1-118. Epub 2010 Dec 1.

Supplemental Content

Support Center